Nanotechnology for biomedical applications - Enhancement of photodynamic activity by nanomaterials

Bulletin of the Polish Academy of Sciences: Technical Sciences

Volumn 59, Issue 3, 2011, Pages 253-262

  Ulatowska Jarza, A ^a   Pucinska J ^a   Wysocka Krol K ^a   Holowacz I ^a   Podbielska, H ^a  

^a WROCLAW UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

Fluorescence enhancement; Photodynamic activity; Silica titania (SiO2 TiO2) materials; Silver doped nanomaterials

Indexed keywords

ALTERNATIVE ENERGY SOURCE; BIOMEDICAL APPLICATIONS; FLUORESCENCE ENHANCEMENT; FLUORESCENCE INTENSITIES; MICRO-SCALES; MOLECULAR LEVELS; PHOTODYNAMIC ACTIVITIES; PHOTOLON; PROTOPORPHYRIN IX; SILICA-TITANIA; TIO; VIS SPECTROSCOPY;

FLUORESCENCE; MEDICAL APPLICATIONS; NANOSTRUCTURED MATERIALS; NANOTECHNOLOGY; SILICA; SILICON COMPOUNDS; SILVER; TITANIUM DIOXIDE;

PHOTOSENSITIZERS;

EID: 81155144672     PISSN: 02397528     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10175-011-0031-0     Document Type: Article

References (91)

1. O.C. Farokhzad and R. Langer, "Nanomedicine: developing smarter therapeutic and diagnostic modalities", Adv. Drug Del. Rev. 58, 1456-1459 (2006). (Pubitemid 44820502)
2. Y. Liu, H. Miyoshi, and M. Nakamura, "Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles", Int. J. Cancer 120, 2527-2537 (2007). (Pubitemid 46651272)
3. D. Peer, J.M. Karp, S. Hong, O.C. Farokhzad, R. Margalit, and R. Langer, "Nanocarriers as an emerging platform for cancer therapy", Nat. Nanotechnol. 2, 751-760 (2007). (Pubitemid 350223348)
4. D.A. Orroner, Y.E. Koo, T. Chen, R. Kopelman, O. Sagher, and M.A. Philbert, "Small solutions for big problems: the application of nanoparticle to brain tumor diagnosis and therapy", Clinical Pharmacol. Ther. 85 (5), 531-534 (2009).
5. L. Zhang, F.X. Gu, J.M. Chan, A.Z. Wang, R.S. Langer, and O.C. Farokhzad, "Nanoparticles in medicine: therapeutic applications and developments", Clinical Pharmacol. Ther 83 (5), 761-769 (2008). (Pubitemid 351556021)
6. G. Szefner and D. Jasińska, "Modeling of strains and stress of material nanostructures", Bull. Pol. Ac: Tech. 57 (1), 41-46 (2009).
7. M. Ferrari, "Cancer nanotechnology: opportunities and challenges", Nat. Rev. Cancer 5, 161-171 (2005). (Pubitemid 40314948)
8. M. Eaton, "Nanomedicine: industry-wise research", Nature Materials 6, 251-253 (2007). (Pubitemid 46516809)
9. Y. Lan, H. Wang, X. Chen, D. Wang, G. Chen, and Z. Ren, "Nanothermometer using single crystal silver nanospheres", Adv. Mater. 21, 1-6 (2009).
10. R. Bawa, "Nanoparticle-based therapeutics in humans: a survey", Nanotech. Law Bus. 5 (2), 135-155 (2008).
11. V. Wagner, A. Dullaart, A.-K. Bock, and A. Zweck, "The emerging nanomedicine landscape", Nat. Biotech. 24, 1211-1217 (2006). (Pubitemid 44564760)
12. M. Knez, "ALD - a versalite tool for nanostructuring", Material Matters 3 (2), 28-30 (2008).
13. G.R Lopinski and D.D.M. Wayner, "Molecular monolayers on silicon surfaces", Material Matters 3 (2), 38-41 (2008).
14. B. Zdyrko, V. Klep, and I. Luzinov, "Universal platform for modification employing grafted polymer layers", Material Matters 3 (2), 44-46 (2008).
15. A. Jaworek, A.T. Sobczyk, A. Krupa, M. Lackowski, and T. Czech, "Electrostatic deposition of nanothin films on metal substrate", Bull. Pol. Ac: Tech. 57 (1), 63-70 (2009).
16. M.A. Fierke, F. Li, and A. SteiFrom, "Form to function: molding porous materials in three dimensions by colloidal crystal templating", Material Matters 3(1), 10-12 (2008).
17. G. Peng, U. Tisch, O. Adams, M. Hakim, N. Shehada, Y. Broza, S. Billan, R. Abdah-Bortnyak, A. Kuten, and H. Haick, "Diagnosing lung cancer in exhaled breath using gold nanoparticles", Nat. Nanotechnol. 4, 669-673 (2009).
18. P. Mazzone, "Sniffing out lung cancer", Nat. Nanotechnol. 4, 621-622 (2009).
19. A. Joshi, S. Punyani, S.S. Bale, H. Yang, T. Borca-Tasciuc, and R.S. Kane, "Nanotube-assisted protein deactivation", Nat. Nanotechnol. 3, 41-45 (2008).
20. W.J. Mulder, D.P. Cormode, S. Hak, M.E. Lobatto, S. Silvera, and Z.A. Fayad, "Multimodality nanotracers for cardiovascular applications", Nat. Clin. Pract. Cardiovasc. Med. 5, 103-111 (2008).
21. M.G. Bredell, E. Besic, C. Maake, and H. Walt, "The application and challenges of clinical PD-PDT in the head and neck region: a short review", J. Photochem. Photobiol. B 101 (3), 185-190 (2010).
22. Photodynamic Medicine, http://www.eppm-photomedicine.org/(2010).
23. A. Sieroń and S. Kwiatek, "Twenty years of experience with PDD and PDT in Poland - review", Photodiag. Photodyn. Ther. 6 (2), 73-78 (2009).
24. R. Allison, H. Mota, V. Bagnato, and C. Sibata, "Bionanotechnology and photodynamic therapy - state of the art review", Photodiag. Photodyn. Ther. 5, 19-28 (2008). (Pubitemid 351337662)
25. H. Podbielska, A. Sieroń, and W. Strȩk, Photodynamic Diagnostics and Therapy, Medical Publishing House, Urban & Partner, Wrocław, 2004, (in Polish).
26. I.H. El-Sayed, X. Huang, and M.A. El-Sayed, "Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles", Cancer Lett. 239, 129-135 (2006). (Pubitemid 43946581)
27. M. MacCormack, Photodynamic Therapy, Adv. Dermatol. 22, 219-258 (2006). (Pubitemid 44960616)
28. P. Rai, S. Mallidi, X. Zheng, R. Rahmanzadeh, Y. Mir, S. Elrington, A. Khurshid, and T. Hasan, "Development and applications of photo-triggered theranostic agents", Adv. Drug Deliv. Rev. 2 (11), 1094-1124(2010).
29. I. Brigger, C. Dubernet, and P. Couvreur, "Nanoparticles in cancer therapy and diagnosis", Adv. Drug Del. Rev. 54, 631-651 (2002). (Pubitemid 35247520)
30. J. Moan and Q. Peng, An Outline of the History of PDT, in: Photodynamic Therapy, pp. 1-18, ed. T. Patrice, The Royal Society of Chemistry, London, 2003.
31. F. Marcucci and F. Lefoulon, "Active targeting with particulate drug carriers in tumor therapy: fundamentals and recent progress", Drug Discov. Today 9 (5), 219-228 (2004). (Pubitemid 38230021)
32. O.M. Koo, I. Rubinstein, and H. Onyuksel, "Role of nanotechnology in targeted drug delivery and imaging: a concise review", Nanomedicine 1, 193-212 (2005). (Pubitemid 43963632)
33. J.F. Lovell, T.W. Liu, J. Chen, and G. Zheng, "Activatable photosensitizers for imaging and therapy", Chem. Rev. 110 (5), 2839-2857 (2010).
34. I. Roy, T.Y. Ohulchanskyy, H.E. Pudavar, E.J. Bergey, A.R. Oseroff, J. Morgan, T.J. Dougherty, and P.N. Prasad, "Ceramic-based nanoparticles entrapping water insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy", J. Am. Chem. Soc. 125, 7860-7865 (2003). (Pubitemid 36782161)
35. S. Sahoo and V. Labhasetwar, "Nanotech approaches to drug delivery and imaging", Drug Discov. Today 8, 1112-1120 (2003). (Pubitemid 37547917)
36. D. Bechet, P. Couleaud, C. Frochot, M.L. Viriot, F. Guillemin, and M. Barberi-Heyob, "Nanoparticles as vehicles for delivery of photodynamic therapy agents", Trends Biotechnol. 26 (11), 612-621 (2008).
37. Y. Konan, M. Berton, R. Gurny, and E. Allémann, "Enhanced photodynamic activity of meso-tetra(4-hydroxyphenyl) porphyrin by incorporation into sub-200 nm nanoparticles", Eur. J. Pharm. Sci. 18, 241-249 (2003). (Pubitemid 36349275)
38. B. Pegaz, E. Debefve, F. Borle, J. Ballini, H. van den Bergh, and Y. Kouakou-Konan, "Encapsulation of porphyrins and chlorins in biodegradable nanoparticles: the effect of dye lipophilicity on the extravasation and the photothrombic activity. A comparative study", J. Photochem. Photobiol. B 80, 19-27 (2005). (Pubitemid 40823836)
39. Y. Konan, R. Cerny, J. Favet, M. Berton, R. Gurny and E. Allémann, "Preparation and characterization of sterile sub-200 nm meso-tetra(4-hydroxylphenyl)porphyrin-loaded nanoparticles for photodynamic therapy", Eur. J. Pharm. Biopharm. 55, 115-124 (2003). (Pubitemid 36120503)
40. A. Vargas, B. Pegaz, E. Debefve, Y. Konan-Kouakoub, N. Lange, J.P. Ballini, H. van den Bergh, R. Gurny, and F. Delie, "Improved photodynamic activity of porphyrin loaded into nanoparticles: an in vivo evaluation using chick embryos", Int. J. Pharm. 286, 131-145 (2004). (Pubitemid 39410481)
41. K.S. Soppimath, T.M. Aminabhavi, A.R. Kulkarni, and W.E. Rudzinski, "Biodegradable polymeric nanoparticles as drug delivery devices", J. Control. Release. 70, 1-20 (2001). (Pubitemid 32144788)
42. E. Ricci-Junior and J. Marchetti, "Zinc(II) phthalocyanine loaded PLGA nanoparticles for photodynamic therapy use", Int. J. Pharm. 310, 187-195 (2006). (Pubitemid 43287983)
43. W. Tang, H. Xu, E.J. Park, M.A. Philbert, and R. Kopelman, "Encapsulation of methylene blue in Polyacrylamide nanoparticle platforms protects its photodynamic effectiveness", Biochem. Biophys. Res. Commun. 369, 579-583 (2008).
44. M.L. Adams, A. Lavasanifar, and G.S. Kwon, "Amphiphilic blockcopolymers for drug delivery", J. Pharm. Sci. 92, 1343-1355 (2003).
45. A. Lavasanifar, J. Samuel, and G. Kwon, "Micelles of poly(ethylene oxide)-block-poly(N-a1kyl stearate L-aspartamide): synthetic analogues of lipoproteins for drug delivery", J. Biomed. Mater. Res. 52 (4), 831-835 (2000).
46. K. Yasugi, Y. Nagasaki, M. Kato, and K. Kataoka, "Preparation and characterization of polymer micelles from poly(ethyIene glycol)-poly(D,L- lactide) block copolymers as potential drug carrier", J. Control. Release 62, 89-100 (1999). (Pubitemid 29486487)
47. C.F. Rijcken, J.W. Hofman, F. van Zeeland, W.E. Hennink and C.F. van Nostrum, "Photosensitiser-loaded biodegradable polymeric micelles: Preparation, characterisation and in vitro PDT efficacy", J. Control. Release 124, 144-153 (2007). (Pubitemid 350101885)
48. C.F. van Nostrum, "Polymeric micelles to deliver photosensitizers for photodynamic therapy", Adv. Drug Del. Rev. 56, 9-16 (2004). (Pubitemid 38045421)
49. J.E. Chung, M. Yokoyama, M. Yamato, T. Aoyagi, Y Samurai, and T. Okano, "Thermo-responsive drug delivery from polymeric micelles constructed using block copolymers of poly(N-isopropylacrylamide) and poly(butylmethacrylate) ", J. Control. Release 61, 115-127(1999). (Pubitemid 29486490)
50. D. Neradovic, C.F. van Rostrum, and W.E. Hennink, "Thermoresponsive polymeric micelles with controlled instability based on hydrolytically sensitive N-isopropylacrylamide copolymers", Macromolecules 34, 7589-7591 (2001). (Pubitemid 33074518)
51. V.P. Torchilin, "PEG-based micelles as carriers of contrast agents for different imaging modalities", Adv. Drug Deliv. Rev. 54, 235-252 (2002). (Pubitemid 34230444)
52. Y. Li, K. Xiao, J. Luo, J. Lee, S. Pan, and K.S. Lam, "A novel size-tunable nanocarrier system for targeted anticancer drug delivery", J. Control. Release 144(3), 314-323 (2010).
53. V.P. Torchilin, "Recent advances with liposomes as pharmaceutical carriers", Nat. Rev. Drug Discov. 4, 145-160 (2005). (Pubitemid 40282557)
54. G. Thurston, J.W. McLean, M. Rizen, P. Baluk, A. Haskell, T.J. Murphy, D. Hanahan, and D.M. McDonald, "Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice", J. Clin. Invest. 101, 1401-1413 (1998). (Pubitemid 28166838)
55. S. Krasnici, A. Werner, M.E. Eichhorn, M. Schmitt-Sody, S.A. Pahernik, B. Sauer, B. Schulze, M. Teifel, U. Michaelis, K. Naujoks, and M. Dellian., "Effect of the surface charge of liposomes on their uptake by angiogenic tumor vessels", Int. J. Cancer 105, 561-567 (2003). (Pubitemid 36578564)
56. Y.N. Konan, R. Gruny, and E. Allémann, "State of art in the delivery of the photosensitizers for photodynamic tharapy", Photochem. Photobiol. B 66, 89-106 (2002). (Pubitemid 34240266)
57. S. Svenson, and D. Tomalia, "Dendrimers in biomedical applications - reflections on the field", Adv. Drug Del. Rev. 57, 2106-2129 (2005). (Pubitemid 41759389)
58. A. Caminade, R. Laurent, and J. Majorai, "Characterization of dendrimers", Adv. Drug Del. Rev. 57, 2130-2146 (2005). (Pubitemid 41759390)
59. K. Kitchens, M.A. El-Sayed, and H. Ghandehar, "Transepithelial and endothelial transport of poly (amidoamine) dendrimers", Adv. Drug Del. Rev. 57, 2163-2176, (2005). (Pubitemid 41759391)
60. R. Duncan and L. Izzo, "Dendrimer biocompatibility and toxicity", Adv. Drug Del. Rev. 57, 2215-2237 (2005). (Pubitemid 41759394)
61. T. Okuda, S. Kawakami, T. Maeie, T. Niidome, F. Yamashita, and M. Hashida, "Biodistribution characteristics of amino acid dendrimers and their PEGylated derivatives after intravenous administration", J. Control. Release 114, 69-77 (2006). (Pubitemid 44128625)
62. I.B. Rietveld, W.G. Bouwman, M.W.P.L. Basra, and R.K. Heenan, "Location of the outer shell and influence of pH on carboxylic acid-functionalized poly(propylene imine) dendrimers", Macromolecules 34, 8380-8383 (2001). (Pubitemid 33074036)
63. M. El-Sayed, M.F. Kiani, M.D. Naimark, A.H. Hilal, and H. Ghandehari, "Extravasation of poly(amidoamine) (PAMAM) dendrimers across microvascular network endothelium", Pharm. Res. 18, 23-28 (2001). (Pubitemid 32299618)
64. R. Jevprasesphant, J. Penny, R. Jalal, D. Attwood, N.B. McKeown, and A. D'Emanuele, "The influence of surface modification on the cytotoxicity of PAMAM dendrimers", Int. J. Pharm. 252, 263-266 (2003). (Pubitemid 36126635)
65. M. El-Sayed, M. Ginski, C. Rhodes, and H. Ghandehari, "Transepithelial transport of poly(amidoamine) dendrimers across Caco-2 cell monolayers", J. Control. Release 81, 355-365 (2002). (Pubitemid 34607155)
66. N. Malik, R. Wiwattanapatapee, R. Klopsch, K. Lorenz, H. Frey, J.W. Weener, E.W. Meijer, W. Paulus and R. Duncan, "Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of I-125-labelled poly(amidoamine) dendrimers in vivo", J. Control. Release 65, 133-148 (2000). (Pubitemid 30122922)
67. M.E. Wieder, D. Hone, M.J. Cook, M.M. Handsley, J. Gavrilovie, and D.A. Russell, "Intracellular photodynamic therapy with photosensitizer- nanoparticle conjugates: cancer therapy using a 'Trojan horse'", Photochem. Photobiol. Sci. 5 (8), 727-734 (2006). (Pubitemid 44186866)
68. L. Czernielewski, G.B. Ekonjo, E. Teterycz, M. Gryboś, and H. Podbielska, "Developments in photodynamic diagnosis and therapy in gynecology - a review", in: Aspects of Photodynamic Medicine II, eds. H. Podbielska, A. Sieroń, W. Strȩk, pp. 177-236, Publishing House Indygo, Wrocław, 2008.
69. K. Wysocka, U. Bindig, J. Bauer, W. Strȩk, K. Kowal, and H. Podbielska, "Silver based nanomaterials - fluorescence enhancement in silver doped silica based nanobiomaterials", Engineering of Biomaterials 81-84, 124-125 (2008).
70. H.A. Isakau, M.V. Parkhats, V.N. Knyukshto, B.M. Dzhagarov, E.P. Petrov, and P.T. Petrov, "Toward understanding the high PDT efficacy of chlorine e6-polyvinylpyrrolidone formulations: photophysical and molecular aspects of photosensitizerpolymer interaction in vitro", J. Photochem. Photobiol. B 92, 165-174 (2008).
71. W.W.L. Chin, P.W.S. Heng, P.S.P. Thong, R. Bhuvaneswari, W. Hirt, S. Kuenzel, K.C. Soo, and M. Olivo, "Improved formulation of photosensitizer chlorin e6 polyvinylpyrrolidone for fluorescence diagnostic imaging and photodynamic therapy of human cancer", Eur. J. Pharm. Biopharm. 69, 1083-1093 (2008).
72. U. Bindig, A. Ulatowska-Jarża, M. Kopaczyńska, G. Müller, and H. Podbielska, "Investigations on photolon- and porphyrindoped sol-gel fiberoptic coatings for laser-assisted applications in medicine", Laser Phys. 18, 1-10 (2008).
73. A. Ulatowska-Jarża, I. Holowacz, K. Wysocka, and H. Podbielska, "Silica-based versus silica-titania sol-gel materials - comparison of the physical properties: surface tension, gelation time, refractive index and optical transmittance", Opt. Appl. 39, 211-220(2009).
74. H. Podbielska, A. Ulatowska-Jarża, J. Bauer, A. Wieliczko, J. Razik, and W. Strȩk, "The comparison of photodynamic activity of Photolon and Protoporphyrine on pathogenic bacteria in vitro", Pol. J. Environ. Stud. 15, 147-151, (2006).
75. Y. Wangi, J. Zhou, R. Zong, S. Shi, T. Wang, and B. Li, "Enhancement effect of terbium complex luminescence by binding to silver nanoparticles in the solution", Optoelectron. Lett. 2, 316-319 (2006).
76. H. Nabika and S. Deki, "Enhancing and quenching functions of silver nanoparticles on the luminescent properties of Europium complex in the solution phase", J. Phys. Chem. B 107 (35), 9161-9164 (2003).
77. S. Areva, V. Ääritalo, S. Tuusa, M. Jokinen, M. Lindén, and T. Peltola, "Sol-gel-derived Ti02-Si02 implant coatings for direct tissue attachment. Part II: Evaluation of cell response", J. Mater. Sci. Mater. Med. 18 (8), 1633-1642 (2007). (Pubitemid 47033873)
78. A. Ochsenbein, F. Chai, S. Winter, M. Traisnel, J. Breme, and H.F. Hildebrand, "Osteoblast responses to different oxide coatings produced by the sol-gel process on titanium substrates", Acta Biomater. 4 (5), 1506-1517 (2008).
79. D. Böeking, J. Fiedler, R.E. Brenner, and R.E. Hüsing, "Cultivation of human fibroblasts and multipotent mesenchymal stromal cells on mesoporous silica and mixed metal oxide films", J. Mater. Sci. 44 (24), 6786-6794 (2009).
80. V. Muhonen, S. Kujala, A. Vuotikka, V. Ääritalo, T. Peltola, S. Areva, T. Närhi, and J. Tuukkanen, "Biocompatibility of sol-gel-derived titania-silica coated intramedullary NiTi nails", Acta Biomater. 5(2), 785-793 (2009).
81. V. Ääritalo, V. Meretoja, T. Tirri, S. Areva, T. Jämsä, J. Tuukkanen, A. Rosling, and T. Närhi, "Development of a low temperature sol-gel-derived titania-silica implant coating", Materials Sciences and Applications 1, 118-126 (2010).
82. M.S.M. Peterson, J. Bouwman, A. Chen, and M. Deutsch, "Inorganic metallodielectric materials fabricated using two single-step methods based on the Tollen's process", J. Colloid Interface Sci. 306, 41-49 (2007). (Pubitemid 44827042)
83. K. Wysocka, A. Leszkiewicz, W. Strȩk, W. Goroszkiewicz, and H. Podbielska, "Silicon nanomaterials doped with silver and their possible applications in biomedicine", Acta Bio-Opt. et Informat. Med. 13 (3), 180-183 (2007), (in Polish).
84. P. Cordiali Fei, A. Macri, E. Trento, G. D'Agosto, D. Griso, F. Biolcati, and F. Ameglio, "Flow cytometric analysis of fluorocytes in patients with erythropoietic porphyria", Eur. J. Histochem. 41 (2), 9-10 (1997).
85. C.-W. Lam, K.-C. Lau, C.M. Mak, M.-W. Tsang, and Y.-W. Chan, "Circulating fluorocytes at the first attack of acute intermittent porphyria: a missing link in the pathogenesis", Clin. Chim. Acta 412 (1-2), 208-212 (2011).
86. A.O. Ribeiro, C.R. Neri, Y. Iamamoto, and O.A. Serra, "Spectroscopic studies on the inclusion complexes of tetrakis(2-hydroxy-5-nitrophenyl) porphyrin with a-cyclodextrin in solution and in sol-gel matrix", Mater. Sci. 20 (1), 21-27 (2002).
87. M. Wieder, D. Hone, M.J. Cook, M.M. Handsley, J. Gavrilovie, and D. Russell, "Intracellular photodynamic therapy with photosensitizer- nanoparticle conjugates: cancer therapy using a Trojan horse", Photochem. Photobiol. Sci. 5, 727-734 (2006). (Pubitemid 44186866)
88. F. Yan and R. Kopelman, "The embedding of metatetra(hydroxyphenyl)- chlorin into silica nanoparticle platforms for photodynamic therapy and their singlet oxygen production and pH-dependent optical properties", Photochem. Photobiol. 78, 587-591 (2003).
89. Z. Lu, F. Ye, and A. Vaidya, "Polymer platforms for drug delivery and biomedical imaging", J. Control. Release 122, 269-277 (2007). (Pubitemid 47404679)
90. B. Pegaz, E. Debefve, J.-P. Ballini, Y. Konan-Kouakou, and H. van den Bergh, "Effect of nanoparticle size on the extravasation and the photothrombic activity of meso(p-tetracarboxyphenyl) porphyrin", J. Photochem. Photobiol. B 85, 216-222 (2006). (Pubitemid 44567380)
91. Carl Schlyter, Report on Regulatory Aspects of Nanomaterials (2008/2208(INI)), Committee on the Environment, Public Health and Food Safety, http://www.europarl.europa.eu/sides/getDoc.do?pubRef=-//EP//TEXT+REPORT+A6-2009- 0255+0+DOC+XML+V0//EN (2009).